Programs Header Scaled Aspect Ratio 1200 384

The Latest from Vor Bio

Vor Bio Blog

Fellowship in Action: Our First In-House Manufacturing Run

Earlier this year, Vor Bio dosed its first patient with VCAR33ALLO, a transplant donor-derived CAR-T targeting CD33 in AML patients. VCAR33ALLO is manufactured at our in-house facility in Cambridge, MA, and Voracians were directly involved in every part of the process. We spoke ...

Confronting Imposter Syndrome & Empowering the AAPI Community: Reflections from Dr. Robert Ang

Who has entered a meeting room full of people and thought “I feel like a total fraud and I don’t belong here?” Me. All the time. As an Asian American, I've navigated a lifelong journey shadowed by the weight of imposter syndrome—a phenomenon I've come to understand is all too familiar among individuals of Asian American and Pacific Islander (AAPI) heritage.

A Generous Gift: My Transplant Journey

By Darren Johnson, Medical Science Liaison

It all started with a blood draw. I was 17 and in the middle of my senior year of high school and my doctor was checking some routine labs. I thought nothing of it as I was a healthy young ...

From Concept to Clinical Trial Results: A Conversation with Glen Raffel, MD, PhD, VP of Clinical Research & Development

As we continue to share results from our first clinical trial, VBP101, we checked in with our Vice President of Clinical Research & Development, Glen Raffel, MD, PhD, to find out what it’s like seeing this concept progress from an idea to a clinical trial where we are now seeing results in patients who have received this drug candidate.

Reflections of a Vor Bio Scientist

Hannah Mager, a beloved Associate Scientist II on our Discovery and Molecular Engineering team, recently concluded her time at Vor Bio to pursue her PhD, and we couldn’t be more proud of her! Prior to her departure, Hannah shared key learnings from her time here and shared advice for other young scientists looking to take the next step in their careers.